Krutishil Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 26 Year, 15 Days
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 4.83 Cr
- Revenue Growth %
- Profit Growth 97.03%
- Ebitda 99.25%
- Net Worth -10.64%
- Total Assets -10.56%
About Krutishil Pharma
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1999PTC117926
-
Company No.
117926
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 1999
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Krutishil Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Parekh
|
Director | 12-Apr-1999 | Current |
|
Malvika Parekh
|
Director | 19-Jan-1999 | Current |
|
Binoy Parekh
|
Director | 12-Apr-1999 | Current |
Financial Performance of Krutishil Pharma.
Krutishil Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krutishil Pharma?
In 2019, Krutishil Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Krutishil Distributors Private LimitedMalvika Parekh, Binoy Parekh and 1 more are mutual person
-
Sainath Agencies (Pharma) Private Limited
Binoy Parekh and Ankit Parekh are mutual person
Charges (Loans)
₹0
₹48.32 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 4.25 Cr
- Deutsche Bank Ag : 0.50 Cr
- Syndicate Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2016 | Axis Bank Limited | ₹4.25 Cr | Satisfied |
| 08 Jan 2014 | Deutsche Bank Ag | ₹5.00 M | Satisfied |
| 23 May 2000 | Syndicate Bank | ₹0.50 M | Satisfied |
| 19 Apr 1999 | Syndicate Bank | ₹0.32 M | Satisfied |
How Many Employees Work at Krutishil Pharma?
Unlock and access historical data on people associated with Krutishil Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krutishil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krutishil Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
